Related Experiment Video
Updated: Jun 4, 2026

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Metastasis: new perspectives on an old problem
Sandra Kraljevic Pavelic1, Mirela Sedic, Hrvojka Bosnjak
1Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia. sandrakp@biotech.uniri.hr
Abstract:
Many hypotheses have been postulated to explain the intricate nature of the metastatic process, but none of them completely accounted for the actual biological and clinical observations. Consequently, metastasis still remains an open issue with only few metastasis-inducing proteins experimentally validated so far. Recently proposed novel metastatic model, where serial and parallel metastatic processes are adequately integrated, might help to bridge the current gap between experimental results and clinical observations. In addition, the identification, isolation and molecular characterization of cancer stem cells, a population of the cells within the tumour mass able to proliferate, self-renew and induce tumorigenesis, will shed new light on the complex molecular events mediating metastasis, invasion and resistance to therapy. Understanding the molecular basis of these tumour characteristics will usher in a new age of individualized cancer therapy. In this review article, we will provide a current overview of molecular mechanisms underpinning metastasis, and discuss recent findings in this field obtained by global molecular profiling strategies such as proteomics.
Insights
Metastasis remains complex, but new models integrating serial and parallel processes, alongside cancer stem cell research, are improving our understanding of tumor spread and therapy resistance. This knowledge advances individualized cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis, the spread of cancer, is poorly understood, with existing hypotheses failing to fully explain clinical observations.
- Few metastasis-inducing proteins have been validated, leaving metastasis as a significant challenge in cancer treatment.
Purpose of the Study:
- To provide an overview of the molecular mechanisms driving metastasis.
- To discuss recent advancements in understanding metastasis, including novel models and cancer stem cell research.
- To highlight the role of global molecular profiling, such as proteomics, in cancer research.
Main Methods:
- Review of current scientific literature on cancer metastasis.
- Analysis of a novel metastatic model integrating serial and parallel processes.
- Discussion of cancer stem cell identification, isolation, and molecular characterization.
- Exploration of findings from global molecular profiling strategies, including proteomics.
Main Results:
- A novel metastatic model offers a more comprehensive explanation for metastasis compared to previous hypotheses.
- Cancer stem cells are identified as key players in tumor proliferation, self-renewal, and tumorigenesis.
- Global molecular profiling, particularly proteomics, yields new insights into the molecular events of metastasis.
Conclusions:
- Understanding the molecular basis of metastasis and cancer stem cells is crucial for developing targeted therapies.
- Advancements in understanding metastasis pave the way for a new era of individualized cancer therapy.
- Proteomics and other profiling strategies are powerful tools for unraveling the complexities of cancer progression.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

